Research

Cellular

Efsubaglutide Alfa showed a preferable tolerability and safety profile.

Efsubaglutide Alfa may be a safer option for weight management compared to other treatments.

StrongSupportsmedium confidence
Efsubaglutide Alfa demonstrated significant weight-loss efficacy, metabolic improvements, and a preferable tolerability and safety profile.
Fei Gao et al. · Diabetes Obesity and Metabolism · 2026

Why this rating

Based on the randomized, double-blind, placebo-controlled trial design.

Source

Efficacy, tolerability, and safety of Efsubaglutide Alfa in participants with obesity or overweight ( <scp>LIGHT</scp> 1): A randomized, double‐blind, placebo‐controlled, ascending‐dose phase 2a trial

Fei Gao et al. · Diabetes Obesity and Metabolism · 2026

DOI 10.1111/dom.70429

rct · n=50
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →